Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM) | LOERadar

Viewing data from:

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM

ANDA

AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM | A207762 | NEOCUBES PHARMA LLP

11 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: CADUET(TE code: AB)

Products (11)

Sort:

#001 — EQ 2.5MG BASE;EQ 10MG BASE

AB

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jan 11, 2019

No patent or exclusivity listings for this strength.

#002 — EQ 2.5MG BASE;EQ 20MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#003 — EQ 2.5MG BASE;EQ 40MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#004 — EQ 5MG BASE;EQ 10MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#005 — EQ 5MG BASE;EQ 20MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#006 — EQ 5MG BASE;EQ 40MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#007 — EQ 5MG BASE;EQ 80MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#008 — EQ 10MG BASE;EQ 10MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#009 — EQ 10MG BASE;EQ 20MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#010 — EQ 10MG BASE;EQ 40MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019

#011 — EQ 10MG BASE;EQ 80MG BASE

AB

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jan 11, 2019